What is "bexarotene"

n. A particular oral antineoplastic drug.

Bexarotene (brand name: Targretin) is an antineoplastic (anti-cancer) agent approved by the U.S. Food and Drug Administration (FDA) (in late 1999) and the European Medicines Agency (EMA) (early 2001) for use as a treatment for cutaneous T cell lymphoma (CTCL). It is a third-generation retinoid.